13F Filings History of THOMASPARTNERS, INC.

13F snapshot Latest parsed holdings, value, and filing-period context. 1 signal
Form 13F summary
  • THOMASPARTNERS, INC. Form 13F history summarizes parsed U.S.-listed equity disclosures for this manager.
  • Form 13F is generally due within 45 days after each calendar quarter ends.
  • THOMASPARTNERS, INC. reported 75 equity holdings with a total reported market value of $13,653,918,000 for Q1 2018. Top reported holdings included MSFT, JNJ, CVX, TXN, and BBT.
Manager Names, identifiers, and filing context for this profile. 2 identity fields
Manager signature
Denise Kampf - Vice President
Manager location
Boston, MA

Follow Filing Activity

Follow THOMASPARTNERS, INC. with Pro and return when a new 13F portfolio filing changes the record on this page.

Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.

Holdings Value

List of Other Managers Reporting for THOMASPARTNERS, INC.:

Name Holdings Value Location File Number
Verity & Verity, LLC $1,453,817,900 Beaufort, SC 028-14888

Form 13F evidence

Quarterly portfolio filings

SEC-reported 13F quarters for this filer, ordered by the latest accepted filing.

Latest quarter
Q1 2018
Latest value
$13,653,918,000
Quarter delta
-$28,661,000
Accepted
02 May 2018, 16:25
Rows shown
1-19 of 19
Quarter Holdings SEC-reported value Bought Sold Net Top Holdings Form Type Accepted by SEC
Q1 2018 75 $13,653,918,000 +$932,377,677 -$529,871,168 +$402,506,509 MSFT, JNJ, CVX, TXN, BBT 13F-HR 02 May 2018, 16:25
Q4 2017 76 $13,682,579,000 +$636,908,868 -$202,001,807 +$434,907,061 JNJ, CVX, XOM, MSFT, TXN 13F-HR 12 Feb 2018, 10:06
Q3 2017 78 $12,499,101,000 +$1,082,589,028 -$611,978,933 +$470,610,095 JNJ, CVX, AMLP, XOM, MSFT 13F-HR 13 Nov 2017, 14:47
Q2 2017 75 $11,634,233,000 +$840,019,923 -$180,654,115 +$659,365,808 JNJ, XOM, PPG, CVX, UTX 13F-HR 11 Aug 2017, 09:09
Q1 2017 79 $10,845,314,000 +$1,247,087,131 -$8,214,415 +$1,238,872,716 JNJ, XOM, CVX, IBM, PPG 13F-HR 04 May 2017, 19:43
Q4 2016 83 $9,226,521,000 +$1,128,043,459 -$260,270,175 +$867,773,284 JNJ, VZ, BBT, IBM, WFC 13F-HR 13 Feb 2017, 06:07
Q3 2016 81 $8,193,115,000 +$528,332,513 -$4,978,875 +$523,353,638 JNJ, IBM, AMLP, NVS, MSFT 13F-HR 14 Nov 2016, 13:56
Q2 2016 80 $7,631,332,000 +$609,555,394 -$224,469,453 +$385,085,941 JNJ, NVS, IBM, XOM, AMLP 13F-HR 09 Aug 2016, 14:41
Q1 2016 84 $6,955,254,000 +$383,658,258 -$182,364,997 +$201,293,261 JNJ, IBM, MSFT, BCE, ES 13F-HR 13 May 2016, 15:42
Q4 2015 85 $6,497,208,000 +$215,479,966 -$19,438,444 +$196,041,522 JNJ, MSFT, LOW, ES, LMT 13F-HR 16 Feb 2016, 15:21
Q3 2015 108 $5,942,461,000 +$414,269,087 -$258,796,755 +$155,472,332 JNJ, BCE, MSFT, ES, LMT 13F-HR 13 Nov 2015, 17:03
Q2 2015 122 $6,191,440,000 +$369,773,617 -$160,005,219 +$209,768,398 JNJ, PFE, AMLP, BCE, MSFT Restatement 19 May 2016, 07:56
Q1 2015 134 $6,152,394,000 +$575,560,236 -$142,974,204 +$432,586,032 PFE, LOW, BCE, JNJ, LMT Restatement 19 May 2016, 07:55
Q4 2014 132 $5,821,518,000 +$731,441,270 -$319,620,067 +$411,821,203 MSFT, PG, BCE, LOW, NU Restatement 19 May 2016, 07:55
Q3 2014 135 $5,135,810,000 +$417,163,343 -$8,403,288 +$408,760,055 MSFT, JNJ, INTC, PG, CVX Restatement 19 May 2016, 07:54
Q2 2014 139 $4,789,716,000 +$675,078,572 -$206,846,373 +$468,232,199 CVX, JNJ, BCE, MSFT, DEO Restatement 19 May 2016, 07:54
Q1 2014 139 $4,170,622,000 +$830,144,114 -$337,939,706 +$492,204,408 CVX, JNJ, PFE, BCE, LMT Restatement 19 May 2016, 07:53
Q4 2013 136 $3,638,735,000 +$873,584,564 -$215,813,577 +$657,770,987 CVX, PPG, LMT, VFC, BCE Restatement 19 May 2016, 07:53
Q3 2013 136 $2,777,484,000 $0 $0 $0 PPG, GPC, EMR, JNJ, LMT Restatement 19 May 2016, 07:52
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .